Open Government Portal
Health Canada is revising the Guidance Document entitled: The Management of Drug Submissions and Applications (MDSA). This document provides sponsors …
Health Canada is issuing this Notice to clinical trial sponsors to clarify the approach to various types of clinical research …
Health Canada is issuing this Notice to clinical trial sponsors to clarify the approach to various types of clinical research …
Health Canada is working on a strategic approach to support the transition of all product monographs into the XML format, …
Health Canada is issuing this notice to communicate the Department's interim approach on the exemption of certain medical gases and …
Health Canada is pleased to announce the fourth publication of the Guidance Document: Certificates of Supplementary Protection.
Health Canada recommends modified wording for the indications and clinical uses of fludeoxyglucose (F-18 FDG) products in their product monographs. …
This document clarifies the requirements to be met for the issuance of a Certificate of a Pharmaceutical Product (CPP) or …
Health Canada will continue to post a monthly table on the Department website which reflects updated and/or new safety information …
The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on …